Larvol Delta - Q32-Bio-Announces-Upcoming-LateBreaking-Presentation-of-Results-from-Part-B-of-the-SIGNALAA-Clinical-Trial-of-Bempikibart-in-Alopecia-Areata-at-the-European-Academy-of-Dermatology-and-Venereology-Congress-2026

bempikibart (ADX-914) - Q32 Bio

https://www.prnewswire.com/news-releases/q32-bio-announces-upcoming-late-breaking-presentation-of-results-from-part-b-of-the-signal-aa-clinical-trial-of-bempikibart-in-alopecia-areata-at-the-european-academy-of-dermatology-and-venereology-congress-2026-302884741.html

Sep 21, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next